Home/Filings/4/0001437749-24-021196
4//SEC Filing

DARGAN CHARLES K 4

Accession 0001437749-24-021196

CIK 0000880242other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 5:59 PM ET

Size

14.1 KB

Accession

0001437749-24-021196

Insider Transaction Report

Form 4
Period: 2024-06-23
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option to purchase common stock

    2024-06-23+700,0004,325,786 total
    Exercise: $0.27From: 2024-06-23Exp: 2034-06-23Common stock (700,000 underlying)
Footnotes (2)
  • [F1]This Option was granted to Reporting Person to replace an option to purchase 300,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
  • [F2]This total reflects the expiration of the option referenced in F1.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001112799

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:59 PM ET
Size
14.1 KB